Jeff Himawan - 26 Sep 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 Sep 2023
Net transactions value
+$446,073
Form type
4
Filing time
27 Sep 2023, 17:13:48 UTC
Previous filing
28 Jul 2023
Next filing
06 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $446,073 +32,161 +260% $13.87* 44,546 26 Sep 2023 Direct F1
holding HZNP Ordinary Shares 7,873 26 Sep 2023 By Pt Rd Foundation
holding HZNP Ordinary Shares 36,609 26 Sep 2023 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -32,161 -100% $0.000000* 0 26 Sep 2023 Ordinary Shares 32,161 $13.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 10,264 shares previously reported as held indirectly by Trust are now held directly.
F2 The stock option is fully vested.